Neuronetics, Inc. (STIM) Dividend History

Company News

• Neuronetics and Greenbrook TMS Announce Closing of Transaction

  Neuronetics, Inc. has successfully completed the acquisition of Greenbrook TMS Inc. The combined company will continue to operate as Neuronetics, Inc. and the Neuronetics shares will continue to trade on the NASDAQ Global Market under the ticker 'STIM'.

  GlobeNewswire Inc.
• Neuronetics (STIM) Expands NeuroStar Portfolio With New Launch

  Neuronetics (STIM) announces the nationwide launch of the Better Me Provider (BMP) program developed in collaboration with TMS medical experts. The BMP program will be part of the company's NeuroStar product line.

  Zacks Investment Research

  Featured Companies: HIMS JYNT MEDP
• Top 5 Health Care Stocks That May Plunge In March

  As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here’s the latest list of major overbought players in this sector. The Pennant Group, Inc. (NASDAQ: PNTG) On Feb. 28, Pennant posted better-than-expected quarterly sales. “We are pleased with our strong finish to 2023 and continued momentum as we enter 2024,” said Brent Guerisoli, Pennant’s Chief Executive Officer. “By executing on our five key focus areas--leadership development, clinical ...

  Benzinga

  Featured Companies: INZY PNTG SPRY